申请人:Speedel Experimenta AG
公开号:EP1816122A2
公开(公告)日:2007-08-08
Use of compounds of the general formula (I)
and pharmaceutically acceptable salt thereof, in which R1, R2, R3, R4, W, X and Z, n and m have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.
通式(I)化合物的使用
及其药学上可接受的盐,其中 R1、R2、R3、R4、W、X 和 Z、n 和 m 的定义详见说明,可用作 β-分泌酶、Chepsin D、plasmepsin II 和/或 HIV 蛋白酶抑制剂。